DUBLIN--(BUSINESS WIRE)--The "Global Schizophrenia Drugs Market: Size, Trends & Forecast (2018-2022)" report has been added to ResearchAndMarkets.com's offering.
The global schizophrenia drugs market has shown rising trends over the past few years and anticipations are made that the market would grow at a steady pace in the next four years i.e. 2018 to 2022, particularly due to increasing prevalence of schizophrenia globally.
The global schizophrenia market is supported by various growth drivers such as increasing number of patients seeking treatment, rising healthcare expenditure, improvement in healthcare infrastructure etc.
Yet the market growth is restrained by some challenges like side-effects associated with drugs, major expiration of patented drugs, and social stigma of mental health conditions.
In the coming years, the market would be primarily driven by technological advancements, new products launch, increasing utilization of long-acting injectable antipsychotics.
The global schizophrenia drugs market is dominated by major players. Eli Lilly & Company, Otsuka Holdings Co., Ltd., Johnson & Johnson, and Alkermes plc are some of the key players operating in the global market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.
Key Topics Covered
1. Executive Summary
2. Introduction
2.1 Mental Disorder: An Overview
2.2 Psychotic Disorder: An Overview
2.3 Schizophrenia: An Overview
3. Global Market Analysis
3.1 Global Schizophrenia Drugs Market Analysis
4. Product Analysis
4.1 Global Schizophrenia Long-Acting Injectables Product Analysis
5. Regional Market Analysis
5.1 The U.S. Schizophrenia Drugs Market Analysis
5.2 European Union Schizophrenia Drugs Market Analysis
5.3 Japan Schizophrenia Drugs Market Analysis
6. Market Dynamics
6.1 Growth Drivers
6.2 Challenges
6.3 Market Trends
7. Competitive Landscape
7.1 Global Schizophrenia Drugs Market Competitive Landscape
7.2 Global Schizophrenia Drugs Market by Players
8. Company Profiles
8.1 Eli Lilly & Company
8.2 Otsuka Holdings Co. Ltd.
8.3 Johnson & Johnson
8.4 Alkermes PLC
For more information about this report visit https://www.researchandmarkets.com/research/9mlfc4/global?w=4
